Home / KEEP BUT DO NOT DISPLAY (page 101)

KEEP BUT DO NOT DISPLAY

Working Overtime Raises Heart Disease Risk

Working Overtime Raises Heart Disease Risk: The study found that, compared with people who did not work overtime, people who worked three or more hours longer than a normal, seven-hour day had a 60 percent higher risk of heart-related problems such as death due to heart disease, non-fatal heart attacks …

Read More »

Newsflash #521

Once Weekly Byetta (Bydureon © ) Delayed 6 Months by the FDA: See this week’s Item #14. FDA Orders Recall of Baxter’s Colleague Volumetric Infusion Pumps: The FDA has notified health care professionals and consumers of a letter sent to Baxter on April 30 ordering the company to recall and …

Read More »

Diabetes Nerve Pain May Worsen at Night

Diabetes Nerve Pain May Worsen at Night: People with diabetic peripheral neuropathy report worst pain at 11 p.m., study finds. People with diabetes-related nerve damage may experience worse pain in the evening hours, preliminary research suggests. If confirmed in larger studies, the findings suggest that people with diabetic peripheral neuropathy …

Read More »

Newsflash #520

FDA orders recall of Baxter’s Colleague Volumetric Infusion Pumps: The FDA has notified health care professionals and consumers of a letter sent to Baxter on April 30 ordering the company to recall and destroy all Colleague Volumetric Infusion Pumps currently used in the United States — there may be as …

Read More »

Changes in Glitazone Use 2003-2009

Changes in Glitazone Use 2003-2009: From 2003 through 2005, glitazone use increased steadily. From February 2005 to January 2007, rosiglitazone use decreased by 16% annually while pioglitazone use increased at an annual rate of 14%. During a period of FDA advisories, rosiglitazone use declined sharply from 0.42 million monthly treatment …

Read More »

Mortality Rates Differ with Different Sulfonylureas

Mortality Rates Differ with Different Sulfonylureas: The risk for overall mortality is similar in patients with Type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy, according to the results of a retrospective cohort study. The findings suggest that glimepiride may be the preferred sulfonylurea in patients with underlying coronary artery …

Read More »

Newsflash #519

Diabetes Linked to Irregular Heartbeat. See this week’s Item #2. Lilly Submits Reply to FDA Complete Response Letter for BYDUREON™. See this week’s Item #7.  

Read More »

US Ponders Populationwide Salt-reduction Policies

US Ponders Populationwide Salt-reduction Policies: In most developed countries, more than 75% of the salt consumed comes from processed foods. The WHO advises that adults consume no more than 5g per day. The average consumption of salt in most Western countries currently stands at around 9g to 12g a day. …

Read More »